Centene and Competitors Feel the Squeeze

  • Centene’s Medicaid pressures cause major insurers’ stocks to drop sharply
  • Medicaid membership expected to level off at 12.9-13 million instead of 13.6 million by year-end
  • Centene reiterates full-year adjusted EPS guidance floor at $6.80
  • More than 25 million people removed from Medicaid rolls since early 2023
  • 30% of terminated individuals return to Centene, but coverage gap widens

Major insurers in the Medicaid business, including Centene, Molina Healthcare, and Elevance Health, experienced significant stock declines after discussing ongoing challenges with the program’s enrollment process. Centene now expects its Medicaid membership to level off at around 12.9-13 million instead of the previous projection of 13.6 million by year-end. Despite reaffirming its full-year adjusted EPS guidance floor at $6.80, Centene’s stock dropped over 8%. Over 25 million people have been removed from Medicaid rolls since early 2023, with 30% of those terminated individuals eventually returning to Centene. However, the coverage gap continues to widen.

Factuality Level: 9
Factuality Justification: The article provides accurate and objective information about the impact of Medicaid redeterminations on major insurers’ stocks and Centene’s expectations for its membership. It cites relevant sources and includes quotes from company executives to support its claims.
Noise Level: 3
Noise Justification: The article provides relevant information about the impact of Medicaid redeterminations on major players in the industry and their stock performance. It also includes quotes from Centene executives and data from a health-policy research nonprofit. However, it lacks analysis or exploration of long-term trends or consequences for those affected by these changes.
Public Companies: Centene Corp. (CNC), Molina Healthcare Inc. (MOH), Elevance Health Inc. (ELV), UnitedHealth Group Inc. (UNH), Wells Fargo & Co. (WFC), S&P 500 (SPX)
Key People: Sarah London (Chief Executive), Drew Asher (Chief Financial Officer)

Track all markets on TradingView

Financial Relevance: Yes
Financial Markets Impacted: Centene Corp., Molina Healthcare Inc., Elevance Health Inc., and UnitedHealth Group Inc. stocks were impacted by the ongoing tumult in the Medicaid business.
Financial Rating Justification: The article discusses the financial performance of major players in the Medicaid industry, including stock price drops, and how it relates to changes in Medicaid enrollment numbers.
Presence Of Extreme Event: No
Nature Of Extreme Event: No
Impact Rating Of The Extreme Event: No
Extreme Rating Justification: There is no extreme event mentioned in the article.
Move Size: The market move size mentioned in this article is a drop of more than 8% for Centene Corp.’s stock, which is its largest percentage decline in nearly four years. Additionally, Molina Healthcare Inc.’s stock dropped by 9%, and Elevance Health Inc.’s stock fell by 4.4%.
Sector: Healthcare
Direction: Down
Magnitude: Large
Affected Instruments: Stocks

Reported publicly: www.marketwatch.com